COVID-19-associated fungal infections

M Hoenigl, D Seidel, R Sprute, C Cunha… - Nature …, 2022 - nature.com
Abstract Coronavirus disease 2019 (COVID-19)-associated invasive fungal infections are an
important complication in a substantial number of critically ill, hospitalized patients with …

Tackling the emerging threat of antifungal resistance to human health

MC Fisher, A Alastruey-Izquierdo, J Berman… - Nature reviews …, 2022 - nature.com
Invasive fungal infections pose an important threat to public health and are an under-
recognized component of antimicrobial resistance, an emerging crisis worldwide. Across a …

Gut microbiota in COVID-19: key microbial changes, potential mechanisms and clinical applications

F Zhang, RI Lau, Q Liu, Q Su, FKL Chan… - Nature Reviews …, 2023 - nature.com
The gastrointestinal tract is involved in coronavirus disease 2019 (COVID-19) caused by
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The gut microbiota has …

The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries

M Hoenigl, D Seidel, A Carvalho… - The Lancet …, 2022 - thelancet.com
Reports of COVID-19-associated mucormycosis have been increasing in frequency since
early 2021, particularly among patients with uncontrolled diabetes. Patients with diabetes …

Increased incidence of candidemia in a tertiary care hospital with the COVID‐19 pandemic

M Nucci, G Barreiros, LF Guimarães… - Mycoses, 2021 - Wiley Online Library
Background The incidence of candidemia in our hospital has been stable over an 18‐year
period (1.3 episodes per 1000 admissions). Since March 2020, we have observed an …

Outbreak of Candida auris infection in a COVID-19 hospital in Mexico

H Villanueva-Lozano… - Clinical …, 2021 - clinicalmicrobiologyandinfection …
Since its emergence in December 2019, the rapid spread of coronavirus disease 2019
(COVID-19) has necessitated the expansion and transformation of healthcare facilities …

COVID-19-associated opportunistic infections: a snapshot on the current reports

A Abdoli, S Falahi, A Kenarkoohi - Clinical and experimental medicine, 2022 - Springer
Abstract Treatment of the novel Coronavirus Disease 2019 (COVID-19) remains a
complicated challenge, especially among patients with severe disease. In recent studies …

The landscape of candidemia during the coronavirus disease 2019 (COVID-19) pandemic

EE Seagle, BR Jackson, SR Lockhart… - Clinical Infectious …, 2022 - academic.oup.com
Background The COVID-19 pandemic has resulted in unprecedented healthcare
challenges, and COVID-19 has been linked to secondary infections. Candidemia, a fungal …

Impact of SARS-CoV-2 epidemic on antimicrobial resistance: a literature review

FV Segala, DF Bavaro, F Di Gennaro, F Salvati… - Viruses, 2021 - mdpi.com
Antimicrobial resistance is an urgent threat to public health and global development; in this
scenario, the SARS-CoV2 pandemic has caused a major disruption of healthcare systems …

Characteristics of candidemia in COVID‐19 patients; increased incidence, earlier occurrence and higher mortality rates compared to non‐COVID‐19 patients

B Kayaaslan, F Eser, A Kaya Kalem, Z Bilgic… - Mycoses, 2021 - Wiley Online Library
Severe COVID‐19 patients in ICU are at high risk for candidemia due to exposure to multiple
risk factors for candidemia. We aimed to compare the incidence of candidemia in ICU …